首页> 美国卫生研究院文献>Oncology Letters >Overexpression of hsa-miR-125a-5p enhances proliferation migration and invasion of head and neck squamous cell carcinoma cell lines by upregulating C-C chemokine receptor type 7
【2h】

Overexpression of hsa-miR-125a-5p enhances proliferation migration and invasion of head and neck squamous cell carcinoma cell lines by upregulating C-C chemokine receptor type 7

机译:hsa-miR-125a-5p的过表达通过上调C-C趋化因子受体7型来增强头颈部鳞状细胞癌细胞系的增殖迁移和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Head and neck squamous cell carcinoma (HNSCC) is usually diagnosed accompanied by lymph node metastasis. C-C chemokine receptor type 7 (CCR7) is associated with the invasion and metastasis of tumors in HNSCC through various signaling pathways. The role of hsa-miR-125a-5p in HNSCC remains unclear. The present study was performed to investigate the association between hsa-miR-125a-5p and CCR7 in HNSCC. Reverse transcription-quantitative polymerase chain reaction was applied to analyze the expression of hsa-miR-125a-5p in clinical samples. Cell Counting Kit-8, Transwell and wound healing assays were used to detect cell proliferation, invasion, and metastasis, respectively, following overexpression of hsa-miR-125a-5p. Changes in protein expression of CCR7 were observed using western blotting. In the survival analysis, Student's t-tests and log rank tests were performed to analyze the association between the expression of hsa-miR-125a-5p, and HNSCC according to the Cancer Genome Atlas database. The expression of hsa-miR-125a-5p was identified to be significantly lower in cancer tissue compared with the corresponding adjacent normal tissues in clinical samples (P=0.038). The results of western blotting indicated that there was a positive regulatory association between hsa-miR-125a-5p and CCR7. Furthermore, overexpression of hsa-miR-125a-5p significantly enhanced the ability of cell proliferation, migration and invasion in HNSCC, with upregulation of CCR7. The results of survival analysis revealed that patients in the low expression group of hsa-miR-125a-5p tended to have longer survival times compared with the high expression group (P=0.045). Altogether, the data raised the possibility that hsa-miR-125a-5p has a significant role in promoting cancer in HNSCC, which may provide a basis for the treatment of HNSCC in molecular targeted therapy. Further studies are required to ascertain the role of hsa-miR-125a-5p in other HNSCC cell lines and in vivo.
机译:通常诊断为头颈部鳞状细胞癌(HNSCC)并伴有淋巴结转移。 C-C趋化因子受体7型(CCR7)通过各种信号通路与HNSCC中肿瘤的侵袭和转移相关。 hsa-miR-125a-5p在HNSCC中的作用尚不清楚。本研究旨在研究HNSCC中hsa-miR-125a-5p与CCR7之间的关联。应用逆转录定量聚合酶链反应分析临床样品中hsa-miR-125a-5p的表达。在hsa-miR-125a-5p过表达后,分别使用Cell Counting Kit-8,Transwell和伤口愈合试验分别检测细胞增殖,侵袭和转移。使用蛋白质印迹观察到CCR7的蛋白表达变化。在生存分析中,根据《癌症基因组图集》数据库,进行了学生t检验和对数秩检验,以分析hsa-miR-125a-5p表达与HNSCC之间的关联。经鉴定,与临床样品中相应的相邻正常组织相比,hsa-miR-125a-5p在癌症组织中的表达明显较低(P = 0.038)。蛋白质印迹的结果表明,hsa-miR-125a-5p与CCR7之间存在正调控关系。此外,hsa-miR-125a-5p的过表达显着增强了HNSCC中细胞增殖,迁移和侵袭的能力,并上调了CCR7。生存分析结果表明,与高表达组相比,hsa-miR-125a-5p低表达组患者的生存时间往往更长(P = 0.045)。总之,数据提出了hsa-miR-125a-5p在促进HNSCC癌变中起重要作用的可能性,这可能为分子靶向治疗中HNSCC的治疗提供基础。需要进一步的研究以确定hsa-miR-125a-5p在其他HNSCC细胞系和体内的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号